Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Magnetic Resonance Imaging | Research article

Use of intravoxel incoherent motion imaging to monitor a rat kidney chronic allograft damage model

Authors: Qiang Zhang, Zexing Yu, Song Zeng, Lu Liang, Yue Xu, Zijian Zhang, Hao Tang, Wenjiao Jiao, Wenrui Xue, Wei Wang, Xiaodong Zhang, Tao Jiang, Xiaopeng Hu

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Chronic allograft damage (CAD) is the leading cause of long-term graft dysfunction. A noninvasive method that can diagnose CAD early and monitor its development is needed.

Methods

Kidneys from Fisher rats were transplanted into Lewis rats to establish a CAD model (n = 20). The control group underwent syngeneic kidney transplantation (n = 20). The serum creatinine of the rats was monitored. At 4, 12, and 20 weeks after modeling, a magnetic resonance imaging (MRI) examination was performed. The apparent diffusion coefficient (ADC), pseudo diffusion coefficient (D*), true diffusion coefficient (D) and perfusion fraction (f) of the two groups were analyzed. Chronic allograft damage index (CADI) scoring was used to evaluate the transplanted kidney specimens. Immunohistochemistry was used to detect the expression of fibrosis markers in the transplanted kidney tissues and to analyze their correlations with all MRI parameters.

Results

The transplanted kidneys in the experimental group developed CAD changes before the appearance of elevated creatinine. The MRI parameters in the experimental group [ADC (1.460 ± 0.109 VS 2.095 ± 0.319, P < 0.001), D (1.435 ± 0.102 VS 1.969 ± 0.305, P < 0.001), and f (26.532 ± 2.136 VS 32.255 ± 4.013, P < 0.001)] decreased, and D* (20.950 ± 2.273 VS 21.415 ± 1.598, P = 0.131) was not significantly different from those in the control group. ADC, D and f were negatively correlated with the CADI and the α-SMA and vimentin expression levels.

Conclusion

Intravoxel incoherent motion (IVIM) imaging could detect CAD earlier than creatinine and reflect the degree of fibrosis in grafts quantitatively.
Literature
1.
go back to reference Vanhove T, Goldschmeding R, Kuypers D. Kidney fibrosis: origins and interventions. Transplantation. 2017;101(4):713–26.PubMedCrossRef Vanhove T, Goldschmeding R, Kuypers D. Kidney fibrosis: origins and interventions. Transplantation. 2017;101(4):713–26.PubMedCrossRef
2.
go back to reference Vincenti F, Rostaing L, Grinyo J, Rice K, Steinberg S, Gaite L, et al. Belatacept and long-term outcomes in kidney transplantation. N Engl J Med. 2016;374(4):333–43.PubMedCrossRef Vincenti F, Rostaing L, Grinyo J, Rice K, Steinberg S, Gaite L, et al. Belatacept and long-term outcomes in kidney transplantation. N Engl J Med. 2016;374(4):333–43.PubMedCrossRef
3.
go back to reference Riella LV, Djamali A, Pascual J. Chronic allograft injury: mechanisms and potential treatment targets. Transplant Rev (Orlando). 2017;31(1):1–9.CrossRef Riella LV, Djamali A, Pascual J. Chronic allograft injury: mechanisms and potential treatment targets. Transplant Rev (Orlando). 2017;31(1):1–9.CrossRef
4.
go back to reference Garcia-Carro C, Dorje C, Asberg A, Midtvedt K, Scott H, Reinholt FP, et al. Inflammation in early kidney allograft surveillance biopsies with and without associated tubulointerstitial chronic damage as a predictor of fibrosis progression and development of de novo donor specific antibodies. Transplantation. 2017;101(6):1410–5.PubMedCrossRef Garcia-Carro C, Dorje C, Asberg A, Midtvedt K, Scott H, Reinholt FP, et al. Inflammation in early kidney allograft surveillance biopsies with and without associated tubulointerstitial chronic damage as a predictor of fibrosis progression and development of de novo donor specific antibodies. Transplantation. 2017;101(6):1410–5.PubMedCrossRef
5.
go back to reference Notohamiprodjo M, Reiser MF, Sourbron SP. Diffusion and perfusion of the kidney. Eur J Radiol. 2010;76(3):337–47.PubMedCrossRef Notohamiprodjo M, Reiser MF, Sourbron SP. Diffusion and perfusion of the kidney. Eur J Radiol. 2010;76(3):337–47.PubMedCrossRef
7.
go back to reference Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497–505.PubMedCrossRef Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497–505.PubMedCrossRef
8.
go back to reference van Baalen S, Leemans A, Dik P, Lilien MR, Ten Haken B, Froeling M. Intravoxel incoherent motion modeling in the kidneys: comparison of mono-, bi-, and triexponential fit. J Magn Reson Imaging. 2017;46(1):228–39.PubMedCrossRef van Baalen S, Leemans A, Dik P, Lilien MR, Ten Haken B, Froeling M. Intravoxel incoherent motion modeling in the kidneys: comparison of mono-, bi-, and triexponential fit. J Magn Reson Imaging. 2017;46(1):228–39.PubMedCrossRef
9.
go back to reference Lutz J, Huang H, Deng M, Wagner B, Roos M, Schmaderer C, et al. The effect of FK778 on the progression of chronic allograft nephropathy in a rat model. Transplantation. 2007;83(6):741–6.PubMedCrossRef Lutz J, Huang H, Deng M, Wagner B, Roos M, Schmaderer C, et al. The effect of FK778 on the progression of chronic allograft nephropathy in a rat model. Transplantation. 2007;83(6):741–6.PubMedCrossRef
10.
go back to reference Yilmaz S, Tomlanovich S, Mathew T, Taskinen E, Paavonen T, Navarro M, et al. Protocol core needle biopsy and histologic chronic allograft damage index (CADI) as surrogate end point for long-term graft survival in multicenter studies. J Am Soc Nephrol. 2003;14(3):773–9.PubMedCrossRef Yilmaz S, Tomlanovich S, Mathew T, Taskinen E, Paavonen T, Navarro M, et al. Protocol core needle biopsy and histologic chronic allograft damage index (CADI) as surrogate end point for long-term graft survival in multicenter studies. J Am Soc Nephrol. 2003;14(3):773–9.PubMedCrossRef
11.
go back to reference Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol. 2005;16(10):3015–26.PubMedCrossRef Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol. 2005;16(10):3015–26.PubMedCrossRef
12.
go back to reference Xu Y, Zhang Q, Xue W, Zeng S, Zhang Z, Zhang X, et al. CXC chemokine receptor 4 (CXCR4) antagonist, a novel pathway to prevent chronic allograft nephropathy. Ann Transplant. 2016;21:728–34.PubMedCrossRef Xu Y, Zhang Q, Xue W, Zeng S, Zhang Z, Zhang X, et al. CXC chemokine receptor 4 (CXCR4) antagonist, a novel pathway to prevent chronic allograft nephropathy. Ann Transplant. 2016;21:728–34.PubMedCrossRef
13.
go back to reference Heemann U, Lutz J. Pathophysiology and treatment options of chronic renal allograft damage. Nephrol Dial Transplant. 2013;28(10):2438–46.PubMedCrossRef Heemann U, Lutz J. Pathophysiology and treatment options of chronic renal allograft damage. Nephrol Dial Transplant. 2013;28(10):2438–46.PubMedCrossRef
14.
go back to reference Broecker V, Mengel M. The significance of histological diagnosis in renal allograft biopsies in 2014. Transpl Int. 2015;28(2):136–43.PubMedCrossRef Broecker V, Mengel M. The significance of histological diagnosis in renal allograft biopsies in 2014. Transpl Int. 2015;28(2):136–43.PubMedCrossRef
15.
go back to reference Cano H, Castaneda DA, Patino N, Perez HC, Sanchez M, Lozano E, et al. Resistance index measured by Doppler ultrasound as a predictor of graft function after kidney transplantation. Transplant Proc. 2014;46(9):2972–4.PubMedCrossRef Cano H, Castaneda DA, Patino N, Perez HC, Sanchez M, Lozano E, et al. Resistance index measured by Doppler ultrasound as a predictor of graft function after kidney transplantation. Transplant Proc. 2014;46(9):2972–4.PubMedCrossRef
16.
go back to reference Zhang Q, Yu Z, Xu Y, Zeng S, Zhang Z, Xue W, et al. Use of contrast-enhanced ultrasonography to evaluate chronic allograft nephropathy in rats and correlations between time-intensity curve parameters and allograft fibrosis. Ultrasound Med Biol. 2016;42(7):1574–83.PubMedCrossRef Zhang Q, Yu Z, Xu Y, Zeng S, Zhang Z, Xue W, et al. Use of contrast-enhanced ultrasonography to evaluate chronic allograft nephropathy in rats and correlations between time-intensity curve parameters and allograft fibrosis. Ultrasound Med Biol. 2016;42(7):1574–83.PubMedCrossRef
17.
go back to reference Grabner A, Kentrup D, Pawelski H, Muhlmeister M, Biermann C, Edemir B, et al. Renal contrast-enhanced sonography findings in a model of acute cellular allograft rejection. Am J Transplant. 2016;16(5):1612–9.PubMedCrossRef Grabner A, Kentrup D, Pawelski H, Muhlmeister M, Biermann C, Edemir B, et al. Renal contrast-enhanced sonography findings in a model of acute cellular allograft rejection. Am J Transplant. 2016;16(5):1612–9.PubMedCrossRef
18.
go back to reference Moreno CC, Mittal PK, Ghonge NP, Bhargava P, Heller MT. Imaging complications of renal transplantation. Radiol Clin N Am. 2016;54(2):235–49.PubMedCrossRef Moreno CC, Mittal PK, Ghonge NP, Bhargava P, Heller MT. Imaging complications of renal transplantation. Radiol Clin N Am. 2016;54(2):235–49.PubMedCrossRef
19.
go back to reference Liang L, Chen WB, Chan KW, Li YG, Zhang B, Liang CH, et al. Using intravoxel incoherent motion MR imaging to study the renal pathophysiological process of contrast-induced acute kidney injury in rats: comparison with conventional DWI and arterial spin labelling. Eur Radiol. 2016;26(6):1597–605.PubMedCrossRef Liang L, Chen WB, Chan KW, Li YG, Zhang B, Liang CH, et al. Using intravoxel incoherent motion MR imaging to study the renal pathophysiological process of contrast-induced acute kidney injury in rats: comparison with conventional DWI and arterial spin labelling. Eur Radiol. 2016;26(6):1597–605.PubMedCrossRef
20.
go back to reference Thoeny HC, De Keyzer F. Diffusion-weighted MR imaging of native and transplanted kidneys. Radiology. 2011;259(1):25–38.PubMedCrossRef Thoeny HC, De Keyzer F. Diffusion-weighted MR imaging of native and transplanted kidneys. Radiology. 2011;259(1):25–38.PubMedCrossRef
21.
go back to reference Rheinheimer S, Schneider F, Stieltjes B, Morath C, Zeier M, Kauczor HU, et al. IVIM-DWI of transplanted kidneys: reduced diffusion and perfusion dependent on cold ischemia time. Eur J Radiol. 2012;81(9):e951–6.PubMedCrossRef Rheinheimer S, Schneider F, Stieltjes B, Morath C, Zeier M, Kauczor HU, et al. IVIM-DWI of transplanted kidneys: reduced diffusion and perfusion dependent on cold ischemia time. Eur J Radiol. 2012;81(9):e951–6.PubMedCrossRef
22.
go back to reference Ding J, Chen J, Jiang Z, Zhou H, Di J, Xing W. Assessment of renal dysfunction with diffusion-weighted imaging: comparing intra-voxel incoherent motion (IVIM) with a mono-exponential model. Acta Radiol. 2016;57(4):507–12.PubMedCrossRef Ding J, Chen J, Jiang Z, Zhou H, Di J, Xing W. Assessment of renal dysfunction with diffusion-weighted imaging: comparing intra-voxel incoherent motion (IVIM) with a mono-exponential model. Acta Radiol. 2016;57(4):507–12.PubMedCrossRef
23.
go back to reference Thoeny HC, De Keyzer F, Oyen RH, Peeters RR. Diffusion-weighted MR imaging of kidneys in healthy volunteers and patients with parenchymal diseases: initial experience. Radiology. 2005;235(3):911–7.PubMedCrossRef Thoeny HC, De Keyzer F, Oyen RH, Peeters RR. Diffusion-weighted MR imaging of kidneys in healthy volunteers and patients with parenchymal diseases: initial experience. Radiology. 2005;235(3):911–7.PubMedCrossRef
24.
go back to reference Togao O, Doi S, Kuro-o M, Masaki T, Yorioka N, Takahashi M. Assessment of renal fibrosis with diffusion-weighted MR imaging: study with murine model of unilateral ureteral obstruction. Radiology. 2010;255(3):772–80.PubMedPubMedCentralCrossRef Togao O, Doi S, Kuro-o M, Masaki T, Yorioka N, Takahashi M. Assessment of renal fibrosis with diffusion-weighted MR imaging: study with murine model of unilateral ureteral obstruction. Radiology. 2010;255(3):772–80.PubMedPubMedCentralCrossRef
25.
go back to reference Strutz F. Pathogenesis of tubulointerstitial fibrosis in chronic allograft dysfunction. Clin Transpl. 2009;23(Suppl 21):26–32.CrossRef Strutz F. Pathogenesis of tubulointerstitial fibrosis in chronic allograft dysfunction. Clin Transpl. 2009;23(Suppl 21):26–32.CrossRef
26.
go back to reference Zhao J, Wang ZJ, Liu M, Zhu J, Zhang X, Zhang T, et al. Assessment of renal fibrosis in chronic kidney disease using diffusion-weighted MRI. Clin Radiol. 2014;69(11):1117–22.PubMedCrossRef Zhao J, Wang ZJ, Liu M, Zhu J, Zhang X, Zhang T, et al. Assessment of renal fibrosis in chronic kidney disease using diffusion-weighted MRI. Clin Radiol. 2014;69(11):1117–22.PubMedCrossRef
27.
go back to reference Hennedige T, Koh TS, Hartono S, Yan YY, Song IC, Zheng L, et al. Intravoxel incoherent imaging of renal fibrosis induced in a murine model of unilateral ureteral obstruction. Magn Reson Imaging. 2015;33(10):1324–8.PubMedCrossRef Hennedige T, Koh TS, Hartono S, Yan YY, Song IC, Zheng L, et al. Intravoxel incoherent imaging of renal fibrosis induced in a murine model of unilateral ureteral obstruction. Magn Reson Imaging. 2015;33(10):1324–8.PubMedCrossRef
Metadata
Title
Use of intravoxel incoherent motion imaging to monitor a rat kidney chronic allograft damage model
Authors
Qiang Zhang
Zexing Yu
Song Zeng
Lu Liang
Yue Xu
Zijian Zhang
Hao Tang
Wenjiao Jiao
Wenrui Xue
Wei Wang
Xiaodong Zhang
Tao Jiang
Xiaopeng Hu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1545-1

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.